In vivo detection of clinically non-apparent ocular surface inflammation in patients with meibomian gland dysfunction-associated refractory dry eye symptoms: a pilot study.
Y QaziA KheirkhahC BlackieA CruzatM TrinidadC WilliamsD R KorbPedram HamrahPublished in: Eye (London, England) (2015)
MGD-associated refractory symptoms and the symptom-sign disparity may be explained by clinically non-apparent, active inflammation of the palpebral conjunctiva as detected by IVCM. These patients may benefit from anti-inflammatory therapy.
Keyphrases
- oxidative stress
- end stage renal disease
- anti inflammatory
- ejection fraction
- chronic kidney disease
- prognostic factors
- diffusion weighted imaging
- peritoneal dialysis
- sleep quality
- stem cells
- computed tomography
- magnetic resonance
- patient reported outcomes
- physical activity
- cell therapy
- replacement therapy
- contrast enhanced